Target intelligence / Profile preview

Sal-like protein 4 messenger RNA 3' untranslated region (SALL4 mRNA 3'-UTR) (SALL4 mRNA 3'-UTR)

Target
SALL4 mRNA 3'-UTR
Molecular classification
RNA, Messenger RNA regulatory region
01

Overview

The Sal-like protein 4 (SALL4) messenger RNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the SALL4 transcript, which encodes a zinc-finger transcription factor essential for embryonic development and the maintenance of stem cell pluripotency (Zhang et al., 2015). While SALL4 is typically silenced in most adult tissues, it is frequently reactivated in various malignancies, including hepatocellular carcinoma (HCC) and acute myeloid leukemia (AML), where it acts as a potent oncofetal protein driving tumor growth and self-renewal (Yong et al., 2013). The 3'-UTR contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that post-transcriptionally control the stability and translation efficiency of the SALL4 message (Cheng et al., 2015). Therapeutic strategies targeting this region, such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), or miRNA mimics, aim to downregulate SALL4 expression to inhibit oncogenic signaling pathways. Because SALL4 is a key driver of cancer stemness, the 3'-UTR represents a high-value target for precision oncology, although challenges include ensuring delivery to target tissues and avoiding developmental toxicity, as SALL4 is a known neo-substrate for teratogenic drugs like thalidomide (Matyskiela et al., 2018).

Other names
SALL4 3'-UTRSpalt-like transcription factor 4 mRNA 3' untranslated regionZNF797 mRNA 3'-UTRSal-like 4 mRNA 3'-UTR
02

Mechanism of action

Binding to the 3'-untranslated region to induce mRNA degradation or inhibit translation, thereby reducing the expression of the SALL4 oncofetal protein.

03

Biological functions

Post-transcriptional regulationmRNA stability regulationTranslation regulationStem cell pluripotency maintenance
04

Disease associations

Hepatocellular carcinomaAcute myeloid leukemiaGerm cell tumorGastric cancerDuane-radial ray syndrome
05

Safety considerations

Teratogenicity (developmental toxicity)Potential depletion of normal hematopoietic stem cellsOff-target RNA binding effects
06

Interacting drugs

miR-107 (experimental)

5 more in the full profile.

07

Biomarkers

SALL4 mRNA expressionSALL4 protein expressionAlpha-fetoprotein (AFP)

Beyond the preview

Go deeper on Sal-like protein 4 messenger RNA 3' untranslated region (SALL4 mRNA 3'-UTR) (SALL4 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sal-like protein 4 messenger RNA 3' untranslated region (SALL4 mRNA 3'-UTR) (SALL4 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call